Clinical Trial: Improving Access to PrEP (HIV Prevention Medication) for People in Underserved Areas of Rio de Janeiro

U.S., May 14 -- ClinicalTrials.gov registry received information related to the study (NCT07584122) titled 'Improving Access to PrEP (HIV Prevention Medication) for People in Underserved Areas of Rio de Janeiro' on April 21.

Brief Summary: This study aims to improve access to HIV prevention using pre-exposure prophylaxis (PrEP) among underserved populations in Rio de Janeiro, including gay and bisexual men, transgender women, and sex workers. Despite the proven effectiveness of PrEP, many people at higher risk of HIV face barriers to accessing and continuing this prevention method, especially those living in socially and economically vulnerable communities.

The study will evaluate whether offering PrEP directly in community-based settings...